Against this backdrop of positive signals for mucosal melanoma observed in ARTISTRY-1, and confirmation that nemvaleukin could be managed effectively and safely in the outpatient environment, how did you approach the design of ARTISTRY-6?

Name: Against this backdrop of positive signals for mucosal melanoma observed in ARTISTRY-1, and confirmation that nemvaleukin could be managed effectively and safely in the outpatient environment, how did you approach the design of ARTISTRY-6?
Uploaded: T00:00:00+00:00

CLICK HERE FOR CME CREDIT Back to Symposium

Created by

Presenter

Richard Carvajal, MD

Deputy Physician-in-Chief and Director of Medical OncologyRoy J. and Tara Zuckerberg Professor in Medical OncologyNorthwell Health Cancer InstituteLake Success, NY